ARMISTICE CAPITAL LLC 13D and 13G filings for Brainstorm Cell Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-15 3:07 pm Purchase | 2025-03-31 | 13G | BRAINSTORM CELL THERAPEUTICS I BCLI | ARMISTICE CAPITAL LLC | 717,500 9.990% | 417,952 (+139.53%) | Filing |
| 2025-02-14 5:25 pm Sale | 2024-12-31 | 13G | BRAINSTORM CELL THERAPEUTICS I BCLI | ARMISTICE CAPITAL LLC | 299,548 4.990% | -7,784,398 (-96.29%) | Filing |
| 2024-11-14 3:24 pm Purchase | 2024-09-30 | 13G | BRAINSTORM CELL THERAPEUTICS I BCLI | ARMISTICE CAPITAL LLC | 8,083,946 9.990% | 8,083,946 (New Position) | Filing |